UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

Multicenter phase II study of bendamustine for relapsed or refractory indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma

Cancer science, 2010-09, Vol.101 (9), p.2059-2064

2010

Link zum Volltext

Verfügbarkeit prüfen

Early disease progression in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy

Cancer science, 2018-06, Vol.109 (6), p.2056-2062

2018

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy for localized gastric mucosa–associated lymphoid tissue lymphoma: long-term outcomes over 10 years

Journal of radiation research, 2017-07, Vol.58 (4), p.537-542

2017

Link zum Volltext

Verfügbarkeit prüfen

Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)

Japanese journal of clinical oncology, 2021-07, Vol.51 (7), p.1059-1066

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic biomarkers in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy

Cancer science, 2014-11, Vol.105 (11), p.1435-1441

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan

Journal of clinical oncology, 2017-01, Vol.35 (1), p.32-39

2017

Link zum Volltext

Verfügbarkeit prüfen

R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203

British journal of haematology, 2024-03, Vol.204 (3), p.849-860

2024

Link zum Volltext

Verfügbarkeit prüfen

Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.3615-3617

2022

Link zum Volltext

Verfügbarkeit prüfen

Malignant lymphoma of the oral cavity: A single-center study of 28 cases

Journal of oral and maxillofacial surgery, medicine, and pathology, 2022-11, Vol.34 (6), p.698-703

2022

Link zum Volltext

Verfügbarkeit prüfen

Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin

Annals of hematology, 2019-07, Vol.98 (7), p.1647-1655

2019

Link zum Volltext

Verfügbarkeit prüfen

Incidence and Risk Factors of Central Nervous System Relapse in Localized Extranodal NK/T-Cell Lymphoma, Nasal Type: An Analysis of Nkea Study

Blood, 2018-11, Vol.132 (Supplement 1), p.2935-2935

2018

Link zum Volltext

Verfügbarkeit prüfen

Early disease progression in patients (pts) with newly diagnosed localized nasal extranodal NK/T-cell lymphoma, nasal type (ENKL) treated with radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.7546-7546

2017

Link zum Volltext

Verfügbarkeit prüfen

EBV-positive Burkitt lymphoma as a late-onset posttransplantion lymphoproliferative disorder after allogeneic stem cell transplantation

International journal of hematology, 2004-05, Vol.79 (4), p.387-389

2004

Link zum Volltext

Verfügbarkeit prüfen

Outcomes and prognostic factors of radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC) for newly diagnosed, localized extranodal NK/T-cell lymphoma, nasal type (ENKL): a cooperative study in Japan

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.7541-7541

2016

Link zum Volltext

Verfügbarkeit prüfen

Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial

The Lancet. Haematology, 2018-11, Vol.5 (11), p.e520-e531

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(78)
Berichte
(2)

Sprache

Englisch
(74)
Japanisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(41)
Humans
(36)
Male
(28)
Female
(22)
Middle Aged
(16)
Adult
(15)
Aged
(14)
Biological And Medical Sciences
(13)
Oncology
(12)
Animals
(10)
Aged, 80 And Over
(8)
Hematology
(8)
Adolescent
(7)
Follow-Up Studies
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
Lymphoma
(7)
Patients
(7)
Proximal Tubule
(7)
Child
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multicenter phase II study of bendamustine for relapsed or refractory indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma

Early disease progression in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy

Radiotherapy for localized gastric mucosa–associated lymphoid tissue lymphoma: long-term outcomes over 10 years

Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy

Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)

Prognostic biomarkers in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy

Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan

R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203

Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma

Interim PET-Guided ABVD or ABVD/Escalated BEACOPP for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma (JCOG1305, INNOVATE-HL study)

Malignant lymphoma of the oral cavity: A single-center study of 28 cases

Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203

Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin

Incidence and Risk Factors of Central Nervous System Relapse in Localized Extranodal NK/T-Cell Lymphoma, Nasal Type: An Analysis of Nkea Study

Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105

Long‐term outcomes and central nervous system relapse in extranodal natural killer/T‐cell lymphoma

Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy

Early disease progression in patients (pts) with newly diagnosed localized nasal extranodal NK/T-cell lymphoma, nasal type (ENKL) treated with radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC)

EBV-positive Burkitt lymphoma as a late-onset posttransplantion lymphoproliferative disorder after allogeneic stem cell transplantation

P-126: The prognostic impact of the UK Myeloma Research Alliance Risk Profile in untreated patients with multiple myeloma who received melphalan, prednisolone, and bortezomib: an ad hoc analysis of JCOG1105

Improved Prognosis of Extranodal NK/T-Cell Lymphoma, Nasal Type (ENKL) of Nasal Origin but Not Extranasal Origin: An Analysis of NKEA Study

Outcomes and prognostic factors of radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC) for newly diagnosed, localized extranodal NK/T-cell lymphoma, nasal type (ENKL): a cooperative study in Japan

Prognostic Value Of LMP1, CLA, NK-Cell Origin, and Pretreatment Bone Marrow EBER-ISH In Localized NK/T-Cell Lymphoma Prospectively Treated With Concurrent Chemoradiotherapy: An Ancillary Study Of Japan Clinical Oncology Group (JCOG) 0211

Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial

Durable Responses with Bendamustine Monotherapy In Patients with Relapsed/Refractory Indolent B-Cell Non-Hodgkin Lymphoma (B-NHL) and Mantle-Cell Lymphoma (MCL): Updated Follow-up Data From a Japanese Multicenter Phase II Study

Suchergebnisse filtern